TE
VKTX icon

Tema ETFs’s Viking Therapeutics VKTX Stock Holding History

Tema ETFs’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Sell
8,426
-5,441
-39% -$176K 0.01% 474
2026
Q1 		$451K Sell
13,867
-180
-1% -$5.79K 0.03% 388
2025
Q4 		$494K Buy
+14,047
New +$498K 0.04% 360
2025
Q3 		– Sell
-19,755
Closed -$524K – 528
2025
Q2 		$524K Buy
19,755
+524
+3% +$13.8K 0.14% 136
2025
Q1 		$464K Sell
19,231
-984
-5% -$31.1K 0.14% 115
2024
Q4 		$813K Buy
+20,215
New +$1.15M 0.34% 72

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Tema ETFs's VKTX Position: Q2 2026 in Review

Tema ETFs reduced its Viking Therapeutics (VKTX) stake by 39% in Q2 2026, selling an estimated $176K and leaving 8,426 shares worth $329K. The position accounts for 0.01% of the portfolio, ranked #474.

Tema ETFs first reported a position in VKTX in Q4 2024 and has held it in 6 quarters since. The position peaked at $813K in Q4 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Tema ETFs held 8,426 shares of Viking Therapeutics worth $329K as of Q2 2026.
  • Tema ETFs sold 5,441 Viking Therapeutics shares in Q2 2026, an estimated $176K.
  • Viking Therapeutics made up 0.01% of Tema ETFs's portfolio in Q2 2026, its #474 holding.
  • Tema ETFs first reported a position in Viking Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Tema ETFs's Viking Therapeutics position peaked at $813K in Q4 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.